カテゴリー： GlobalInfoResearch, 世界

結核診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Tuberculosis Diagnostics and Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102008）・商品コード：GIR9102008
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：139
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、結核診断および治療の世界市場について調べ、まとめました。種類別セグメントは、皮膚試験、実験室試験等、用途別セグメントは、病院、クリニック、その他等に区分しました。結核診断および治療の世界市場概観、企業動向、企業別結核診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・結核診断および治療の市場概観
・結核診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・結核診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向
・結核診断および治療の世界市場規模
・結核診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・結核診断および治療のアメリカ市場規模推移
・結核診断および治療のカナダ市場規模推移
・結核診断および治療のメキシコ市場規模推移
・結核診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・結核診断および治療のドイツ市場規模推移
・結核診断および治療のイギリス市場規模推移
・結核診断および治療のロシア市場規模推移
・結核診断および治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・結核診断および治療の日本市場規模推移
・結核診断および治療の中国市場規模推移
・結核診断および治療の韓国市場規模推移
・結核診断および治療のインド市場規模推移
・結核診断および治療の東南アジア市場規模推移
・結核診断および治療の南米市場分析（ブラジル、アルゼンチン等）
・結核診断および治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・結核診断および治療の種類別分析/販売量、売上、市場シェア（皮膚試験、実験室試験）
・結核診断および治療の用途別分析/市場規模（病院、クリニック、その他）
・結核診断および治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・結核診断および治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Tuberculosis refer to the infectious bacterial disease characterized by the growth of nodules (tubercles) in the tissues, especially the lungs.

Scope of the Report:
The global Tuberculosis Diagnostics and Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Diagnostics and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Tuberculosis Diagnostics and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Diagnostics and Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Skin Testing
Laboratory Testing

Market Segment by Applications, can be divided into
Hospital
Clinic
Other

【レポートの目次】

Table of Contents

1 Tuberculosis Diagnostics and Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics and Treatment
1.2 Classification of Tuberculosis Diagnostics and Treatment by Types
1.2.1 Global Tuberculosis Diagnostics and Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Types in 2018
1.2.3 Skin Testing
1.2.4 Laboratory Testing
1.3 Global Tuberculosis Diagnostics and Treatment Market by Application
1.3.1 Global Tuberculosis Diagnostics and Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tuberculosis Diagnostics and Treatment Market by Regions
1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnostics and Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Tuberculosis Diagnostics and Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Cepheid Inc
2.1.1 Business Overview
2.1.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Becton Dickinson
2.2.1 Business Overview
2.2.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hain LifeSciences
2.3.1 Business Overview
2.3.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Alere, Inc
2.5.1 Business Overview
2.5.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche AG
2.6.1 Business Overview
2.6.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Hologic Corporation
2.7.1 Business Overview
2.7.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 bioMerieux
2.8.1 Business Overview
2.8.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 QIAGEN
2.10.1 Business Overview
2.10.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Akonni Biosystems, Inc.
2.11.1 Business Overview
2.11.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Epistem Holdings Plc
2.12.1 Business Overview
2.12.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Gen-Probe Inc.
2.13.1 Business Overview
2.13.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 EIKEN Chemical
2.14.1 Business Overview
2.14.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 Thermo Fisher Scientific, Inc
2.15.1 Business Overview
2.15.2 Tuberculosis Diagnostics and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Tuberculosis Diagnostics and Treatment Market Competition, by Players
3.1 Global Tuberculosis Diagnostics and Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnostics and Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Diagnostics and Treatment Players Market Share
3.3 Market Competition Trend
4 Global Tuberculosis Diagnostics and Treatment Market Size by Regions
4.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
5 North America Tuberculosis Diagnostics and Treatment Revenue by Countries
5.1 North America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
5.2 USA Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
6 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries
6.1 Europe Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
6.2 Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
6.4 France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
7.2 China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
7.5 India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
8 South America Tuberculosis Diagnostics and Treatment Revenue by Countries
8.1 South America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
8.2 Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Tuberculosis Diagnostics and Treatment by Countries
9.1 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
10 Global Tuberculosis Diagnostics and Treatment Market Segment by Type
10.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Type (2019-2024)
10.3 Skin Testing Revenue Growth Rate (2014-2024)
10.4 Laboratory Testing Revenue Growth Rate (2014-2024)
11 Global Tuberculosis Diagnostics and Treatment Market Segment by Application
11.1 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2014-2019)
11.2 Tuberculosis Diagnostics and Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2019-2024)
12.1 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2019-2024)
12.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Regions (2019-2024)
12.3 North America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
12.6 South America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Tuberculosis Diagnostics and Treatment Picture
Table Product Specifications of Tuberculosis Diagnostics and Treatment
Table Global Tuberculosis Diagnostics and Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Types in 2018
Figure Skin Testing Picture
Figure Laboratory Testing Picture
Table Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Application (2014-2024)
Figure Tuberculosis Diagnostics and Treatment Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Market Tuberculosis Diagnostics and Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Cepheid Inc Basic Information, Manufacturing Base and Competitors
Table Cepheid Inc Tuberculosis Diagnostics and Treatment Type and Applications
Table Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table Becton Dickinson Tuberculosis Diagnostics and Treatment Type and Applications
Table Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hain LifeSciences Basic Information, Manufacturing Base and Competitors
Table Hain LifeSciences Tuberculosis Diagnostics and Treatment Type and Applications
Table Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Tuberculosis Diagnostics and Treatment Type and Applications
Table Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Alere, Inc Basic Information, Manufacturing Base and Competitors
Table Alere, Inc Tuberculosis Diagnostics and Treatment Type and Applications
Table Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche AG Basic Information, Manufacturing Base and Competitors
Table Roche AG Tuberculosis Diagnostics and Treatment Type and Applications
Table Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hologic Corporation Basic Information, Manufacturing Base and Competitors
Table Hologic Corporation Tuberculosis Diagnostics and Treatment Type and Applications
Table Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table bioMerieux Basic Information, Manufacturing Base and Competitors
Table bioMerieux Tuberculosis Diagnostics and Treatment Type and Applications
Table bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Tuberculosis Diagnostics and Treatment Type and Applications
Table Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Tuberculosis Diagnostics and Treatment Type and Applications
Table QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Akonni Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Type and Applications
Table Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Epistem Holdings Plc Basic Information, Manufacturing Base and Competitors
Table Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Type and Applications
Table Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Gen-Probe Inc. Basic Information, Manufacturing Base and Competitors
Table Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Type and Applications
Table Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table EIKEN Chemical Basic Information, Manufacturing Base and Competitors
Table EIKEN Chemical Tuberculosis Diagnostics and Treatment Type and Applications
Table EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific, Inc Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Type and Applications
Table Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue Share by Players (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Players in 2017
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2018
Figure Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Regions in 2018
Figure North America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure South America Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table North America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
Table North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2018
Figure USA Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table Europe Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2018
Figure Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure UK Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2018
Figure China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table South America Tuberculosis Diagnostics and Treatment Revenue by Countries (2014-2019)
Table South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2018
Figure Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue Share by Type (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Type (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Type in 2019
Table Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Type (2019-2024)
Figure Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Type (2019-2024)
Figure Global Skin Testing Revenue Growth Rate (2014-2019)
Figure Global Laboratory Testing Revenue Growth Rate (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue by Application (2014-2019)
Table Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Share by Application in 2019
Table Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Application (2019-2024)
Figure Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Tuberculosis Diagnostics and Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Tuberculosis Diagnostics and Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
Figure Europe Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
Figure South America Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Cepheid Inc、Becton Dickinson、Hain LifeSciences、Abbott Laboratories、Alere, Inc、Roche AG、Hologic Corporation、bioMerieux、Sanofi、QIAGEN、Akonni Biosystems, Inc.、Epistem Holdings Plc、Gen-Probe Inc.、EIKEN Chemical、Thermo Fisher Scientific, Inc、

★調査レポート[結核診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102008)販売に関する免責事項を必ずご確認ください。
★調査レポート[結核診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 胃がんの検査・治療・予防の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102024 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、胃がんの検査・治療・予防の世界市場について調べ、まとめました。種類別セグメントは、検査、治療、予防等、用途別セグメントは、病院、診療所、その他等に区分しました。胃がんの検査・治療・予防の世界市場概観、企業動向、企業別胃がんの検査・治療・予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・胃がんの検査・治療・予防の市場概観 ・胃がんの検査・治療・予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・胃がんの検査・治療・予防の企業別販売動向、市場シェア、市場集中度、競争動向 ・胃がんの検査・治療・予防の世界市場規模 ・胃がんの検査・治療・予防の北米市場分析（アメリカ、カナダ、メキシコ等） ・胃がんの検査・治療・予防のアメリカ市場規模推移 ・胃がんの検査・治療・予防のカナダ市場規模推移 ・胃がんの検査・治療・予防のメキシコ市場規模推移 ・胃がんの検査・治療・予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years. There may be no symptoms of stomach cancer early on. Later, symptoms include feeling bloated after eating, feeling full after eating small amounts of food, nausea, heartburn, or indigestion. Scope of the Report: The global Gastric Cancer Testing, Treatment and Prevention market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR...
  • 緑内障治療装置の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101566 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、緑内障治療装置の世界市場について調べ、まとめました。種類別セグメントは、緑内障ドレナージ装置、緑内障レーザー装置等、用途別セグメントは、病院、診療所、その他等に区分しました。緑内障治療装置の世界市場概観、メーカー動向、メーカー別緑内障治療装置シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・緑内障治療装置の市場概観 ・緑内障治療装置の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・緑内障治療装置の企業別販売動向、市場シェア、市場集中度、競争動向 ・緑内障治療装置の世界市場規模 ・緑内障治療装置の北米市場分析（アメリカ、カナダ、メキシコ等） ・緑内障治療装置のアメリカ市場規模推移 ・緑内障治療装置のカナダ市場規模推移 ・緑内障治療装置のメキシコ市場規模推移 ・緑内障治療装置のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Glaucoma is a condition that causes damage to your eye's optic nerve and gets worse over time. Glaucoma treatment device is also possible to be divided into glaucoma laser devices and glaucoma drainage devices. Scope of the Report: The worldwide market for Glaucoma Treatment Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Glaucoma Treatment Devices in global market, especially in North America, Europe and Asia-Pacific,...
  • エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102023 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、エキソソーム診断および治療の世界市場について調べ、まとめました。種類別セグメントは、機器、試薬、ソフトウェア等、用途別セグメントは、診断、治療等に区分しました。エキソソーム診断および治療の世界市場概観、企業動向、企業別エキソソーム診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エキソソーム診断および治療の市場概観 ・エキソソーム診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エキソソーム診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・エキソソーム診断および治療の世界市場規模 ・エキソソーム診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・エキソソーム診断および治療のアメリカ市場規模推移 ・エキソソーム診断および治療のカナダ市場規模推移 ・エキソソーム診断および治療のメキシコ市場規模推移 ・エキソソーム診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. Scope of the Report: The global Exosome Diagnostics and Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America,...
  • 体外診断システムの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103417 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、体外診断システムの世界市場について調べ、まとめました。種類別セグメントは、血液検査、尿検査等、用途別セグメントは、分子診断、臨床化学、糖尿病およびグルコース検査、免疫化学、血液学、その他等に区分しました。体外診断システムの世界市場概観、企業動向、企業別体外診断システムシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・体外診断システムの市場概観 ・体外診断システムの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・体外診断システムの企業別販売動向、市場シェア、市場集中度、競争動向 ・体外診断システムの世界市場規模 ・体外診断システムの北米市場分析（アメリカ、カナダ、メキシコ等） ・体外診断システムのアメリカ市場規模推移 ・体外診断システムのカナダ市場規模推移 ・体外診断システムのメキシコ市場規模推移 ・体外診断システムのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...In vitro diagnostics are diagnostic tests that that can detect diseases, conditions or infections. Scope of the Report: The global In Vitro Diagnostics Systems market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might...
  • 糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102025 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、糖鎖生物学（診断と治療）の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、クリニック、病院、その他等に区分しました。糖鎖生物学（診断と治療）の世界市場概観、企業動向、企業別糖鎖生物学（診断と治療）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・糖鎖生物学（診断と治療）の市場概観 ・糖鎖生物学（診断と治療）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・糖鎖生物学（診断と治療）の企業別販売動向、市場シェア、市場集中度、競争動向 ・糖鎖生物学（診断と治療）の世界市場規模 ・糖鎖生物学（診断と治療）の北米市場分析（アメリカ、カナダ、メキシコ等） ・糖鎖生物学（診断と治療）のアメリカ市場規模推移 ・糖鎖生物学（診断と治療）のカナダ市場規模推移 ・糖鎖生物学（診断と治療）のメキシコ市場規模推移 ・糖鎖生物学（診断と治療）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research. Scope of the Report: Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function. Glycosylation defines the adhesive...
  • 自動車表面処理/熱処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103059 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、自動車表面処理/熱処理の世界市場について調べ、まとめました。種類別セグメントは、化学処理、熱処理、その他等、用途別セグメントは、乗用車、商用車等に区分しました。自動車表面処理/熱処理の世界市場概観、企業動向、企業別自動車表面処理/熱処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・自動車表面処理/熱処理の市場概観 ・自動車表面処理/熱処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・自動車表面処理/熱処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・自動車表面処理/熱処理の世界市場規模 ・自動車表面処理/熱処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・自動車表面処理/熱処理のアメリカ市場規模推移 ・自動車表面処理/熱処理のカナダ市場規模推移 ・自動車表面処理/熱処理のメキシコ市場規模推移 ・自動車表面処理/熱処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Heat treatment and surface modification are the key technologies available today, to enhance the effective use of materials, to achieve the desired properties of the components used in the automotive industries, to save energy and conserve natural resources. Scope of the Report: Heat treatment is a type of surface treatment that includes hardening and thermal diffusion. The global Automotive Surface Treatment/Heat Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in...

    • ◆H&Iグローバルリサーチのお客様（例）◆